Cargando…

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study

It is expected that rapid genetic counseling and testing (RGCT) will lead to increasing numbers of breast cancer (BC) patients knowing their BRCA1/2 carrier status before primary surgery. Considering the potential impact of knowing one’s status on uptake and timing of risk-reducing contralateral mas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wevers, M. R., Schmidt, M. K., Engelhardt, E. G., Verhoef, S., Hooning, M. J., Kriege, M., Seynaeve, C., Collée, M., van Asperen, C. J., Tollenaar, R. A. E. M., Koppert, L. B., Witkamp, A. J., Rutgers, E. J. T., Aaronson, N. K., Rookus, M. A., Ausems, M. G. E. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559099/ https://www.ncbi.nlm.nih.gov/pubmed/25700605 http://dx.doi.org/10.1007/s10689-015-9788-x

Ejemplares similares

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2019)

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
por: van Sprundel, T C, et al.
Publicado: (2005)

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
por: Schmidt, MK, et al.
Publicado: (2005)

Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial
por: Wevers, M R, et al.
Publicado: (2014)

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
por: Kriege, M, et al.
Publicado: (2014)

Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment
por: van Dijk, S, et al.
Publicado: (2003)

Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS)
por: Clarijs, Marloes E, et al.
Publicado: (2023)

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial
por: Saadatmand, Sepideh, et al.
Publicado: (2012)

Robotic nipple-sparing mastectomy complication rate compared to traditional nipple-sparing mastectomy: a systematic review and meta-analysis
por: Filipe, M. D., et al.
Publicado: (2021)

A preliminary prediction model for potentially guiding patient choices between breast conserving surgery and mastectomy in early breast cancer patients; a Dutch experience
por: Vos, Elvira, et al.
Publicado: (2017)

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers
por: Kriege, Mieke, et al.
Publicado: (2015)

Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study
por: van Barele, Mark, et al.
Publicado: (2022)

Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk
por: Liu, Jingjing, et al.
Publicado: (2016)

Predictors of patients’ choices for breast-conserving therapy or mastectomy: a prospective study
por: Molenaar, S, et al.
Publicado: (2004)

Breast cancer genetic counseling among Dutch patients from Turkish and Moroccan descent: participation determinants and perspectives of patients and healthcare professionals
por: Baars, J.E., et al.
Publicado: (2017)

Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study)
por: Terra, Lara, et al.
Publicado: (2021)

MUTYH gene variants and breast cancer in a Dutch case–control study
por: Out, Astrid A., et al.
Publicado: (2012)

Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population
por: van den Broek, Alexandra J, et al.
Publicado: (2015)

Interhospital referral of colorectal cancer patients: a Dutch population-based study
por: Warps, A. K., et al.
Publicado: (2021)

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study
por: Akdeniz, Delal, et al.
Publicado: (2021)

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases
por: Huijts, Petra EA, et al.
Publicado: (2007)

The effect of attendance in the Dutch breast cancer screening program on breast tumor characteristics among migrant women
por: Dassen, R.R.E., et al.
Publicado: (2023)

Repeated Nipple Fluid Aspiration: Compliance and Feasibility Results from a Prospective Multicenter Study
por: de Groot, J. S., et al.
Publicado: (2015)

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age
por: Drooger, Jan C., et al.
Publicado: (2015)

BREAST-Q Breast-Conserving Therapy Module: Normative Data from a Dutch Sample of 9059 Women
por: Oemrawsingh, Arvind, et al.
Publicado: (2022)

Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
por: de Jonge, Marthe M, et al.
Publicado: (2021)

A 10-Year Evaluation of Short-Term Outcomes After Synchronous Colorectal Cancer Surgery: a Dutch Population-Based Study
por: Warps, A. K., et al.
Publicado: (2021)

Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: Design of a multicenter randomized clinical trial
por: Wevers, Marijke R, et al.
Publicado: (2011)

Quality of Life and Complications after Nipple- versus Skin-Sparing Mastectomy followed by Immediate Breast Reconstruction: A Systematic Review and Meta-Analysis
por: Clarijs, Marloes E., et al.
Publicado: (2023)

Effect of a health literacy training program for surgical oncologists and specialized nurses on disparities in referral to breast cancer genetic testing
por: van der Giessen, Jeanine A.M., et al.
Publicado: (2021)

Breast sensibility after mastectomy and implant-based breast reconstruction
por: Bijkerk, E., et al.
Publicado: (2019)

Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients
por: Bock, G H de, et al.
Publicado: (2001)

Rates of re‐excision and conversion to mastectomy after breast‐conserving surgery with or without oncoplastic surgery: a nationwide population‐based study
por: Heeg, E., et al.
Publicado: (2020)

Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients
por: Papelard, H, et al.
Publicado: (2000)

Gender-affirming Mastectomy with Concurrent Oncologic Mastectomy
por: Boyd, Carter J., et al.
Publicado: (2022)

Health-related Quality of Life using the EQ-5D-5L: normative utility scores in a Dutch female population
por: Clarijs, Marloes E., et al.
Publicado: (2022)

De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
por: Simons, J. M., et al.
Publicado: (2020)

Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
por: Lammens, C. R. M., et al.
Publicado: (2010)

Prophylactic Mastectomy in BRCA1/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer Clinic
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2007)

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
por: Zhang, Xi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ifu44mul0uuja5gj5kvq3hvh80